Global campaign launched urging Johnson & Johnson to reduce price of bedaquiline

Médecins Sans Frontières launches a global campaign calling on Johnson & Johnson to lower the price of bedaquiline to no more than US$1 per day.

Read More →

TB drug delamanid must be more affordable and made available in more countries

Médecins Sans Frontières acknowledges the lower price offered to the government of South Africa for delamanid, but calls for it to be significantly lower and expanded to all countries in need.

Read More →

Global Fund donors pledge US$14 billion in fight to end epidemics

Donors at the Global Fund's Sixth Replenishment Conference pledged US$14.02 billion for the next three years – the largest amount ever raised for a multilateral health organization, and the largest amount by the Global Fund.

Read More →

Urgent funding boost and "reality check" needed to sustain HIV and TB progress

In advance of Global Fund replenishment conference, MSF releases report showing that many countries are not financially ready to cover HIV/TB response alone as global funding and political interest wanes.

Read More →

The Union announces Survivors Summit

The Summit will take place on the eve of the 50th Union World Conference on Lung Health to be held on 30 October - 2 November 2019 in Hyderabad, India.

Read More →

TAG welcomes unprecedented U.S. support for TB research, urges all countries to increase investments

TAG welcomes the news of increased investment from the U.S. government in TB research and development; urges all countries to follow through on commitments made at the 2018 UN High-Level Meeting on TB.

Read More →

MSF technical brief: Making the switch

Saving more lives with optimal treatment for drug-resistant TB.

Read More →

FDA approves pretomanid for highly drug-resistant forms of TB

Pretomanid receives FDA approval in combination regimen with bedaquiline and linezolid for people with XDR-TB or treatment-intolerant/non-responsive MDR-TB.

Read More →

Practice-based recommendations for the management of RR/MDR-TB

Statement from DR-TB STAT and TAG outlining practice-based recommendations for the optimal management of RR/MDR-TB. 

Read More →

TAG’s 2019 Pipeline Report: Pediatric TB section released

The section provides an overview of research and development of innovations for diagnosing, preventing, treating TB in children.

Read More →

Page 1 of 100 · Total posts: 10

1 2 Last→